(Total Views: 676)
Posted On: 12/06/2022 11:25:20 AM
Post# of 148894
Took a trip through the slides and was struck by two quick thoughts:
1) the slide face up shows the explosive growth in trading volume, over 5 billion in 2020 that coincided with the prospect Leronlimab may play a role with the pandemic virus shaking the planet.
2) There have been additional trial results from other indications since then that shows Leronlimab will likely play a role in NASH and Cancer which have shook the human race in more palpable ways than covid19. Meanwhile our trading volume (and price) has shrunk back and looking more like pre-covid19.
Cyrus et al need to light the match, be it partnership, buyout or approval-level results that sets the nuclear fusion reaction going and generates the kind of trading volumes birthed from a news spotlight on a treatment for medical ailments that impact most people on the planet. Not expecting that to happen this week but I hope we achieve 20/20 clarity not on the steps that “could” but WILL make it happen.
1) the slide face up shows the explosive growth in trading volume, over 5 billion in 2020 that coincided with the prospect Leronlimab may play a role with the pandemic virus shaking the planet.
2) There have been additional trial results from other indications since then that shows Leronlimab will likely play a role in NASH and Cancer which have shook the human race in more palpable ways than covid19. Meanwhile our trading volume (and price) has shrunk back and looking more like pre-covid19.
Cyrus et al need to light the match, be it partnership, buyout or approval-level results that sets the nuclear fusion reaction going and generates the kind of trading volumes birthed from a news spotlight on a treatment for medical ailments that impact most people on the planet. Not expecting that to happen this week but I hope we achieve 20/20 clarity not on the steps that “could” but WILL make it happen.
(7)
(0)Scroll down for more posts ▼
